Product pipeline
MediaPharma is committed to developing innovative products designed to safely and effectively treat patients with cancer and other severe diseases and improve their outcomes.
LG1 & LG2Therapeutic ProteinsPreclinical
| Product | Description | Status |
| MP-EV-20 | Humanized Anti HER-3 Antibody | Preclinical |
| MP-EV20-89Zr | EV20 conjugated with an immune-PET tracer | Preclinical |
| MP-1959 (SP-2)–ADC | Anti-LGALS3BP Antibody-Drug Conjugate | Preclinical |
| MP-EV20/1959 | Humanized bispecific antibody against HER-3 and LGALS3BP | Preclinical |
| MP-TEM-1-ADC
|
TEM-1/endosialin Antibody-Drug Conjugate | Preclinical |
| MP-E-8-3/1959 | Humanized bispecific antibody against Endosialin and LGALS3BP | Preclinical |
| MP-HER3-ADC | HER3 Antibody-Drug Conjugate | Preclinical |
